Research

Medical Sciences

Title :

A phase 2a double-blind, placebo-controlled randomized clinical trial to evaluate immunogenicity & safety of a Zika virus vaccine (Bbv121) in Dengue sero-negative & dengue sero-negative & Dengue sero-positive healthy adults

Area of research :

Medical Sciences

Focus area :

Task Force (TF)

Principal Investigator :

Mr. M.V. Murhekar Director All India Institute of Medical Sciences Delhi

Timeline Start Year :

2020

Timeline End Year :

2021

Details

Total Budget (INR):

5,57,41,775

Organizations involved